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To track epitope-specific CD4+ T cells at a single-cell level during influenza infection, the MHC class II-restricted OVA323–339 epitope
was engineered into the neuraminidase stalk of influenza/A/WSN, creating a surrogate viral antigen. The recombinant virus, influenza A/
WSN/OVAII, replicated well, was cleared normally, and stimulated both wild-type and DO11.10 or OT-II TCR transgenic OVA-specific
CD4+ T cells. OVA-specific CD4 T cells proliferated during infection only when the OVA epitope was present. However, previously primed
(but not naive) transgenic CD4+ T cells were recruited to the infected lung both in the presence and absence of the OVA323–339 epitope. These
data show that, when primed, CD4+ T cells may traffic to the lung in the absence of antigen, but do not proliferate. These results also
document a useful tool for the study of CD4 T cells in influenza infection.
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The importance of CD4+ T cells in protection against
viral pathogens is well documented. In murine models of
viral infection, CD4+ T cells are necessary for the
production of protective antibody, as well as formation of
fully functional, long-lived effector and memory CD8+ T
cells (Cardin et al., 1996; Matloubian et al., 1994; Riberdy
et al., 2000). The mechanisms used by CD4+ T cells to help
in both long-lived antiviral antibody production and
augmentation of effector CD8+ CTLs for the formation of
memory are not completely understood. These studies have
been confounded, in part, by the lack of readily available
tools to effectively identify and track populations of antigen-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Class I tetramer technology has provided tremendous
insight into the nature of antigen-specific CD8+ T cells at
the single-cell level. However, similar methods for CD4+ T
cells have been slower to develop.
Influenza infection has a number of features that make it
a useful pathogen for study of T cell immune responses.
Upon intranasal inoculation, the virus infects murine lung
epithelium and is readily cleared at sublethal doses by CD8+
CTL and antibody (Doherty et al., 1997; Walker et al.,
1992). The productive infection is localized to the lung
tissue, and no persisting virus can be detected (Eichelberger
et al., 1991). These features make influenza infection a good
model for the study of both the effector and memory phases
of a T cell response.
The ability to genetically engineer influenza virus has
become a useful tool for research. The reverse genetics
method for engineering recombinant negative-strand viruses05) 296 – 306
Fig. 1. Modification of influenza A/WSN neuramindase to include
OVA323 – 339 sequence and kinetics of viral replication and clearance. A)
Map of the neuraminidase gene of parental A/WSN/33, and the modified
A/WSN-OVAII. Reverse genetics (Enami et al., 1990; Luytjes et al., 1989)
were employed to exchange the amino acid sequence for NA43– 58 with
the sequence for OVA323 – 339. Solid line indicates parental sequence;
OVA323 – 339 peptide is bracketed. B) Kinetics of viral replication and
clearance of primary WSN-OVAII infection in C57BL/6 mice. 500 plaque-
forming units (PFU) WSN-OVAII was administered intranasally (i.n.) to 8
week-old female mice. Individual lungs were homogenized and titered for
virus via MDCK plaque assay. Data points represent individual mice, with
3–5 animals per time point, and values expressed as log10 PFU per ml of
lung homogenate.
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Luytjes et al., 1989), and recent technological advances
have developed more efficient means of engineering
viruses in this way (Neumann and Kawaoka, 2001;
Neumann et al., 1999). These viruses have proven useful
in a wide array of research areas, including studies on viral
pathogenicity, vaccine design, and the introduction and
expression of foreign antigen (Maassab and Bryant, 1999;
Neumann and Kawaoka, 2001). Several recombinant
influenza viruses have been shown to productively infect
cells and present engineered epitopes in the context of both
MHC Class I and Class II (Castrucci et al., 1994; Garcia-
Sastre et al., 1994; Miyahira et al., 1998; Nimmerjahn
et al., 2003; Strobel et al., 2000). The utility of this system
to study antiviral CD8 T cell responses was demonstrated
with influenza A/WSN/OVAI (WSN-OVAI), a recombinant
influenza containing OVA257–264 (Topham et al., 2001).
For T helper responses, Walker et al. (1997) found that a
recombinant influenza containing the HEL46–63 epitope
engineered into the neuraminidase (NA) stalk activated
3A9-TCR transgenic (Tg) CD4+ T cells (specific for
HEL46–63) in an MHC-restricted manner. This demonstra-
ted that engineering MHC Class II-restricted immunogenic
epitopes into the NA stalk of influenza allowed for
processing and presentation of that epitope in the context
of infection. We have used this technology to create
influenza A/WSN/OVAII (WSN-OVAII), a novel recombi-
nant influenza virus with the peptide OVA323–339 inserted
into the viral NA stalk.
The addition of an ovalbumin epitope to influenza has
several advantages over other approaches to prime influ-
enza- or OVA-specific CD4 T cells. Priming of OVA-
specific CD4+ T cells during an infectious inflammatory
response is less artificial than injection of high concen-
trations of purified or synthetic antigen. The infection is
localized compared to several other OVA-transfected
pathogens such as vaccinia and listeria (Pope et al.,
2001; Restifo et al., 1995). Compared to other transgenic
models for influenza, this system has the advantage of
being able to track the antigen-specific CD4 T cells with
defined antibodies. In the HNT CD4 TCR transgenic
system, for example, there is neither a clonotypic antibody
nor an allotype marker that can be used to track the cells in
vivo. Thus, we have a system to track antigen-specific
CD4 T cells at the single cell level during a respiratory
infection.
Using this approach, we can further investigate which
components of an immune response are required for
proliferation versus recruitment of virus-specific CD4+ T
cells to the site of infection. For example, it has been
suggested that the proliferation and endothelial cell trans-
migration of human CD4+ T cells in response to antigen
are mutually exclusive responses (Marelli-Berg et al.,
1999). In addition, previous reports have demonstrated
that OVA-primed TH2 cells can be recruited to the lung in
the presence of viral infection, LPS, or IgE cross-linkingwithout specific antigen (Stephens and Chaplin, 2002;
Stephens et al., 2002). For CD8+ T cells, it has been
shown that activation requires specific antigen, but recently
activated or memory cells could be recruited to the lung in
an antigen-nonspecific manner during influenza infection
(Topham et al., 2001).
This work focuses on the use of a novel viral system to
study the recruitment and proliferation of naive and/or
primed antigen-specific CD4+ T cells during infection.
These studies extend previous work by measuring the
kinetics of antigen-specific CD4+ T cell recruitment to
lung tissue, as well as expansion and cytokine secretion
during the acute response. We show that the requirement
for antigen by CD4+ T cells differs with regard to
recruitment and proliferation. The experiments establish
the utility of the WSN-OVAII system for study of antigen-
specific CD4+ T cell responses during respiratory virus
infection.
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WSN-OVAII virus
Engineering of the WSN-OVAII virus involved replace-
ment of a segment of the neuraminidase (NA) stalk by
OVA323–339 (Fig. 1A). The resulting virus, with NA43–58
(Harley et al., 1989) replaced by OVA323–339, contained a
slightly longer NA stalk. Since changes to the NA stalk of
influenza can affect the efficiency of viral escape from host
cells (Castrucci and Kawaoka, 1993), it was important to
confirm that the modified WSN-OVAII virus could replicate
in vivo. The lungs of wild-type C57BL/6 (B6) mice were
sampled at varying time points during primary infection
with WSN-OVAII. Virus peaked at day 6 post-infection, was
rapidly reduced to minimal titers by day 10, and became
undetectable in all mice tested by day 14 (Fig. 1B). The
virus titers and clearance were not different than thatFig. 2. Kinetics of the cellular immune response to acute WSN-OVAII infection. C
(BAL), lung, mediastinal lymph node (MLN) and spleen (SPL) were sampled at s
NP264 – 272-specific CD8
+ responses by IFN-g ELISpot; SFCs: spot-forming cells
infection was also compared to two endogenous CD4+ T cell epitopes, NA161 – 17
experiments and reflects pooled cells from each organ with 4–6 mice per time p
infiltration during WSN-OVAII infection by staining isolated cells with phycoeryt
flow cytometric analysis. Total cell numbers were calculated by multiplying the pe
the mean of 3 mice per time point.obtained after infection with other recombinant WSN
influenza viruses (data not shown).
Cellular immune response to WSN-OVAII infection
To test whether the engineered OVA epitope would
be presented in the context of infection, mice were inocu-
lated with 500 pfu WSN-OVAII intranasally, and ELISpot
assays were performed over the infection course. Indeed,
OVA323–339-specific CD4
+ T cells secreting IFN-g were
detectable throughout the course of infection (Fig. 2A). This
antigen-specific responsewas characterized by a defined peak
on day 9 and was accompanied by increased cellularity in the
lung and airway (BAL) (Fig. 2D), and correlated well with the
decrease in viral load observed between days 8 and 10 post-
infection (Fig. 1B).
Since our virus stocks were generated in embryonated
chicken eggs, the possibility existed that the OVA323–33957BL/6 mice were given 500 PFU WSN-OVAII i.n. Bronchoalveolar lavage
everal time points after infection for A) OVA323 – 339-specific CD4
+ and B)
. C) The OVA323 – 339-specific IFN-g response (black bars) at day 9 post-
5 (gray bars) and HA91– 105 (white bars). Data are representative of repeat
oint. D) BAL and lung samples were analyzed for CD4+ and CD8+ T cell
hrin (PE) conjugated anti-CD4 and Trichrome-conjugated anti-CD8 prior to
rcent CD4+ or CD8+ by the total cells recovered from the organ. Results are
Fig. 3. Presence of OVA323 – 339-specific CD4
+ T cell memory and recall
responses following WSN-OVAII infection. Following infection with 500
PFU WSN-OVAII, animals were allowed to clear the virus and then
assayed at day 30 post-infection by cytokine ELISpot. Briefly, single cell
suspensions of enriched CD4+ T cells isolated from lung, MLN, or spleen
of 5–10 mice per experiment were cultured on cytokine antibody coated
plates for 20 h with either whole, live WSN-OVAII virus (MOI = 2) (A) or
3Ag/ml OVA323 – 339 (B). Bars represent the mean spot forming cells (SFC)
per million CD4+ lymphocytes, and error bars indicate the standard
deviation of triplicate wells. C) The CD4+ recall response in the lung
against OVA323 – 339 was tested 4 weeks after infection with WSN-OVAII
by intranasal LPS/OVA instillation. Control animals had not been infected
with WSN-OVAII. At day 5 after LPS/OVA administration, cells from BAL
and lung were measured for IFN-g and IL-2 secretion by ELISpot. Control
animals were also assayed at day 7 for IL-2 production to be sure that a
response had developed. Error bars indicate the standard deviation of
triplicate wells. b.d. = below detection.
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in the inoculum. Three pieces of evidence made this
unlikely. One, the ovalbumin content of the allantoic fluid
is negligible by days 9–10 of gestation, and the allantoic
virus suspensions are diluted 1000-fold before inoculation.
Secondly, there was no detectable OVA323–339 response in
mice inoculated with WSN-recombinant influenzas missing
the OVA323–339 epitope. Thirdly, mice inoculated with
allantoic fluid from uninfected day 9 embryonated chicken
eggs did not have a detectable ovalbumin-specific immune
response in the lung (data not shown), even when OVA-
specific CD4 T cells had been transferred (Table 1).
Together, these data support the conclusion that the
OVA323–339 response detected in the WSN-OVAII-infected
mice was against the inserted epitope and not to contam-
inating ovalbumin from the eggs used to grow the virus.
In the WSN-OVAII-infected mice, the highest frequen-
cies of antigen-specific T cells were found in the infected
lung and airways (Fig. 2A), and low in the MLN and spleen.
When compared to the CD8+ T cell response against the
influenza nucleoprotein epitope (NP264–272), the kinetics of
the CD4+ and CD8+ T cell responses were nearly identical
(Figs. 2A, B), but the magnitude of the OVA323–339
response was approximately 10-fold lower in frequency
(Fig. 2A) than that of the CD8+ NP264–272 response (Fig.
2B). However, the OVA323–339 response was intermediate
in frequency compared to CD4 T cell responses against two
recently defined endogenous influenza epitopes, NA161–175
and HA91–105 (Crowe et al., in press) within the neuramin-
dase and hemagglutinin proteins, respectively (Fig. 2C).
This suggests that the magnitude and kinetics of cytokine
response to OVA323–339 is comparable to that of endoge-
nous influenza peptide responses.
Recall potential of OVA323–339-specific cells primed by
WSN-OVAII
An interesting feature of the primary CD4+ T cell
response elicited by the WSN-OVAII infection was that,
although there was a substantial population of OVA323–339-
specific cells in the lung and BAL during the acute phase,
there were relatively few cells in the MLN and spleen (Fig.
2A). Furthermore, in recovered animals, the OVA323–339-
specific CD4+ response had fallen to levels at or below theTable 1
Frequency and number of OT-II cells recovered day 9 post-treatment
Treatment BAL Lung
Frequencya Numberb Frequency Number
103 103
WSN-OVAII 2.120 3286 0.995 846
Control WSN 0.078 77 0.152 79
Allantoic fluid 0.467 4 0.155 28
Uninfected 0.765 14 0.098 16
a Frequency calculated from percentage of CD4+ Thy1.2+ cells in the lymphoc
b Numbers were calculated from the frequencies multiplied by the total cell coulimit of detection (<20/106) of the assays in the MLN and
spleen, while the response in the lung tissue was just above
the limit of detection (Fig. 3B). This was in contrast to the
response to whole virus, to which robust virus-specificMLN Spleen Totals
Frequency Number Frequency Number
103 103
4.710 29,438 1.110 111,000 144,569
0.168 1008 0.191 19,100 20,264
0.127 91 0.229 22,900 23,023
0.192 5 0.200 20,000 20,034
yte gate.
nts for each organ.
Fig. 4. OVA323 – 339 TCR transgenic cells are activated and recruited to the
lung in response to WSN-OVAII infection. 1  107 DO11.10 or OT-II
spleen cells from TCR transgenic mice were transferred i.v. into,
respectively, BALB/c or B6.PL (Thy1.1+) congenic recipients 1 day prior
to i.n. infection with 500 PFU WSN-OVAII. At day 9 post-infection, BAL,
lung and MLN of recipients were stained with antibodies to CD4, CD44
and either the clonotypic Ab KJ126 against DO11.10 T cells (A) or the
congenic marker Thy 1.2 against OT-II donor cells (B). The stained cells
were analyzed by flow cytometry. Two parameter plots indicate the
proportion (%) of donor CD4+ KJ126+ or CD4+ Thy1.2+ cells in the organ
specified using a live lymphocyte gate. Activation status of the cells is
indicated in the single parameter histograms by the mean fluorescent
intensity of CD44 staining on the gated (boxed) Thy1.2+ CD4+ cells.
Dotted histogram line represents CD44 staining of OT-II cells in the spleen
of uninfected mice. Data are representative of 4 mice per experiment.
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detectable in recovered animals (Fig. 3A, note scale). The
data show that a relatively small population of flu-primed
CD4+ T cells might persist in the airways, spread over a
greater number of single epitopes, especially compared to
the CD8 response elicited by the same virus.
These observations raised questions regarding the func-
tional qualities of a recall CD4+ response in the lung should
antigen be re-encountered. To study the recall response of
OVA-specific CD4+ T cells primed by the virus infection,
mice were inoculated with WSN-OVAII and then allowed to
clear the virus. Thirty days later, WSN-OVAII immune or
uninfected cohorts were administered OVA323–339 with LPS
by intranasal route. The WSN-OVAII immune cohort
exhibited a strong OVA323–339-specific response by day 5
of LPS/OVA challenge, an early response characteristic of
immune animals that was not detectable at day 5 in the
unprimed mice (Fig. 3C). In the unprimed cohort, a
predominantly IL-2 secreting (Fig. 3C) response to
OVA323–339 was detectable at day 7, with few IFN-g-
secreting cells (data not shown). Both the rapid response and
differentiated cytokine pattern exhibited in the WSN-OVAII
immune mice suggest that a functional resident memory
population of OVA323–339-specific CD4
+ T cells exists.
Single cell analysis of CD4+ T cells in WSN-OVAII infection
Having demonstrated that WSN-OVAII could elicit an
OVA323–339-specific response from wild-type CD4
+ T
cells, we sought to determine whether the CD4+ T cell
response to influenza infection could be followed at the
single cell level. Another advantage of the OVA323–339
epitope is that it is restricted by two distinct class II MHC
alleles expressed by H-2d BALB/c and H-2b C57/BL6
mice (Robertson et al., 2000). This allows investigation of
an influenza primed CD4 response in two distinct genetic
backgrounds. We used either IAd restricted DO11.10 (on
BALB/c background) or IAb-restricted OT-II (on C57BL/6
background) OVA323 – 339-specific transgenic T cells.
Another advantage over the wild-type or HNT systems is
that the specific cells could be followed both in uninfected
mice, or those infected with an otherwise identical virus
missing the OVA epitope.
Unprimed DO11.10 or OT-II spleen cells were adop-
tively transferred to the appropriate BALB or B6.PL naive
recipients prior to infection with WSN-OVAII or a control
WSN virus that contained an irrelevant epitope. On day 9,
the animals were sampled for the presence of either KJ126+
(DO11.10Y BALB) or Thy1.2+ (OT-IIY B6.PL) CD4+ T
cells. WSN-OVAII infection resulted in recruitment of
substantial numbers of both types of transgenic T cells to
the lung and BAL during the peak of infection (Figs. 4A,
B). As expected, these cells were uniformly CD44high (Figs.
4A, B), reflecting efficient activation (DeGrendele et al.,
1997a, 1997b; Eichelberger et al., 1991; Ewing et al., 1995)
in vivo by this virus. Though no transgenic CD4+ T cellsappeared in the lung or airways of uninfected mice, a small
number of CD44high transgenic CD4+ cells were detected in
mice infected with a control influenza virus lacking the
OVA sequence (data not shown). This opened the question
as to whether the few cells observed in the control animals
were a contaminating, primed population from the trans-
genics, or cells activated and recruited non-specifically by
the virus infection.
Role of antigen in recruitment of naive OT-II CD4+ cells
To determine whether naive CD4+ T cells could be non-
specifically activated and recruited to the lung by an
antigenically unrelated virus infection, we sorted CD44low
CD4+ T cells from unprimed Thy1.2+ OT-II donors and
transferred 5  105 per mouse into Thy1.1+ congenic
T.J. Chapman et al. / Virology 340 (2005) 296–306 301recipients. The animals were left alone (uninfected) or
infected with either WSN-OVAII or a control WSN
influenza virus without the OVA sequence. Mock infection
with allantoic fluid from uninfected eggs was used as a
second negative control for non-specific activation of
transgenic cells. As in the previous experiments, WSN-
OVAII infection resulted in substantial activation and
recruitment of the OT-II cells to the infected lung (Table
1 and data not shown). However, though OT-II cells could
be detected in the lymph nodes and spleen, the frequency
and number of OT-II cells in the lung tissue or airways of
mice infected with control WSN were not different from
either uninfected or allantoic fluid inoculated animals
(Table 1). The total number of OT-II cells in the MLN of
the control flu infected mice was higher than in the
uninfected and mock-infected nodes, but the frequencies
in these three groups were essentially the same, so the
difference is due to the overall increase in cellularity of this
node in the infection and does not reflect any selective
recruitment or expansion of the OT-II cells. In fact, an
increase in the overall number of OT-II cells recovered was
apparent only in the WSN-OVAII-infected mice (Table 1).
This clearly demonstrates that T cell activation via specific
antigen is required for expansion and recruitment of naive
CD4+ T cells during influenza infection.
Role of antigen in the recruitment of primed CD4+ T cells to
the lung
The previous experiments looked at the ability of WSN-
OVAII to activate and recruit unprimed or naive CD4
+ T
cells. The first series of experiments with unsorted cells
suggested that some previously activated CD4+ T cells
might be non-specifically recruited to the lung during
infection. To determine whether primed CD4+ T cells could
be non-specifically recruited to the lung, in vitro primed,
TH1 polarized OT-II cells were adoptively transferred prior
to infection.
OT-IIxB6.PL (Thy1.1+) CD4+ T cells were stimulated
with OVA323–339 peptide in vitro for 4 days along withFig. 5. Recruitment of in vitro activated TH1 OT-II cells by WSN-OVAII infectio
culture with 10 Ag/ml OVA323 – 339 peptide, 10 Ag/ml a-CD28, 10 ng/ml rIL-2, 5
congenic hosts, 5  106/ mouse. Recipient mice were left untreated, given contro
MLN, a mixture of peripheral lymph nodes that do not drain the respiratory tract (P
flow cytometry by measuring the frequency of CD4+, Thy1.1+, Va2+, Vh5+ cells.
deviations indicated.IL-12 and anti-IL-4 mAb, then washed and transferred into
Thy1.2+ B6 recipients. Cohorts were left uninfected,
inoculated with control virus or WSN-OVAII. Thy1.1
+
OT-II CD4+ T cells could be detected in the lungs of
infected mice regardless of which virus was present.
However, infection with WSN-OVAII resulted in increased
cell recovery from the airways, lung, and MLN over control
virus infection (Fig. 5), suggesting that the presence of
specific antigen in these sites promoted the recruitment or
retention of specific CD4+ T cells. Few cells were found in
lymph nodes that did not drain the infected lung. Though
not all possible organs were examined, the net number of
OT-II cells recoverable from the animals was the same in
both WSN-OVAII (4.9  106) and control (5.5  106)
influenza-infected mice, both higher than in the uninfected
controls (2.9  106). Together the data suggest that infection
is not a requisite for bystander recruitment of previously
activated TH1 cells to the lung, since cell recovery from
BAL, lung, and MLN were similar in the control virus and
no infection groups (Fig. 5). However, it suggests infection
may promote the non-specific expansion or survival of
previously activated CD4+ T cells.
Antigen-specific proliferation of CD4+ T cells in response to
influenza infection
To distinguish whether the increased cell recovery in the
lung and BAL was due to proliferation, unprimed CD4+
TCR transgenic T cells were CFSE-labeled prior to adoptive
transfer and infection the next day with WSN-OVAII or
control virus. In mice receiving unprimed (but not sorted)
CD4+ T cells, identical numbers of transgenic cells were
detected by flow cytometry in both groups 48 h after
transfer (1 day after infection), indicating that the adoptive
transfer efficiency was satisfactory in both groups. At day 5
post-infection, WSN-OVAII-infected mice had large num-
bers of transgenic T cells actively proliferating in the MLN,
with few proliferating cells found in the lung tissue and
spleen (Fig. 6A). This correlates well with the observations
in wild-type mice without adoptively transferred transgenicn. OT-II cells were isolated and polarized in vitro to a TH1 phenotype by
ng/ml rIL-12 and 10 Ag/ml a-IL4 antibody for 4 days prior to transfer into
l WSN virus, or WSN-OVAII i.n. Seven days after infection, BAL, Lung,
LN) and spleen were removed and numbers of OT-II cells were assessed via
Data represent the mean percentages of 4 mice per experiment with standard
Fig. 6. Failure of TCR transgenic CD4+ cells to proliferate in the absence of
specific antigen. A) DO11.10 spleen cells were labeled with CFSE and
transferred i.v. into BALB/c hosts 1 day prior to infection with WSN-OVAII
or a OVA323 – 339-deficient control WSN influenza virus. At day 5 post-
infection, cells isolated from the indicated organs were assayed via flow
cytometry for dilution of CFSE labeling after gating on CD4+ Thy1.2+ cells.
B) OT-II cells were differentiated in vitro as described in Fig. 5 and
transferred into naive congenic hosts by i.v. injection to rest them for 5 days.
After the 5-day rest period, CD4+ Thy1.2+ donor cells were re-isolated by
flow cytometric sorting and 3 106 cells per mouse were i.v. transferred into
another set of C57BL/6 hosts. These mice were then left uninfected or
infected withWSN-OVAII or controlWSN. BrdUwas injected i.p. on the day
of transfer, and supplied in drinking water for up to 6 days post-infection. At
day 6 post-infection, the donor Thy1.2+ CD4+ cells were assayed for percent
BrdU+. Results for pooled BAL from 4 mice are displayed.
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not detectable until around day 6 (Fig. 2A). Interestingly, in
control influenza-infected mice, though little to no dilution
of CFSE was apparent (Fig. 6A), a population of donor
CFSE+ cells could still be recovered from the lung and
MLN of the control virus group, lending further support of
bystander recruitment of CD4+ T cells during influenza
infection, and suggesting that non-specific recruitment and
proliferation of CD4+ T cells can be uncoupled.In addition to studies with unprimed cells, TH1-primed
transgenic cells were also tested for their ability to proliferate
in the absence of specific antigen. In vitro polarized TH1
cells were rested via injection into naive hosts for 1 week.
These cells were then re-isolated and injected i.v. into hosts
that subsequently received no infection, control virus, or
WSN-OVAII. Transgenic cell proliferation was monitored by
BrdU incorporation. Fig. 6B shows substantial BrdU
incorporation by CD4+ T cells in the airways of WSN-
OVAII-infected mice at 6 days post-infection. BrdU levels in
control virus-infected mice, on the other hand, were not
different from uninfected controls. Together with the data
from Fig. 5 above, the findings suggest little non-specific
expansion of primed CD4+ T cells occurs in the absence of
antigen, even though there is some evidence of antigen-
independent trafficking to the lung. The fact that we
observed proliferation, but no increase in cell recovery of
donor TH1 OT-II cells in WSN-OVAII-infected mice over
control WSN infection could be explained by either
increased apoptosis of the antigen-activated cells, decreased
apoptosis of transgenic cells in the control-infected mice, or
distribution to other tissues that were not sampled. Inves-
tigations are underway to resolve this dilemma.Discussion
We have shown WSN-OVAII is an extremely useful tool
for the study of CD4+ T cell biology during viral infection.
The insertion of the class II MHC-restricted OVA323–339
epitope into the virus did not alter the infection significantly
from that of similar influenza viruses containing an antigeni-
cally neutral engineered epitope. In addition, the generation
of a specific CD4+ T cell response against OVA323–339
suggests the engineered OVA323–339 epitope is efficiently
presented during the infection. Using defined OVA323–339-
specific TCR transgenic cells showed the responding cells
were activated and recruited to the lung tissue, where they
contributed to the overall flu response by secreting IFN-g.
Of note is the low frequency, and number, of the OVA-
specific response in both wild-type B6 and adoptive trans-
fer systems. The frequencies of CD4 T cell responses to
two other, recently identified, immunodominant class II
restricted, endogenous epitopes in influenza virus were,
respectively, higher or lower than the response to the
inserted OVA epitope. Thus, the OVA-specific response in
the context of influenza is in the same range as the responses
to naturally occurring epitopes. The data suggest that class II
restricted CD4+ T cell responses to individual influenza
virus epitopes, on the whole, are programmed to be low in
frequency and abundance. This is compared to the
substantial response to whole virus, suggesting the overall
response must be spread among many epitopes. Similar
results were observed after infection with a natural murine
respiratory virus, Sendai virus (Ewing et al., 1995). These
observations raise doubts as to the utility of class II MHC
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for accurately enumerating the CD4+ T cell response to
infection, especially in the memory phase. The low
frequencies of single-epitope-specific CD4+ T cells will
make it a challenge to reliably see the antigen-specific cells
above background unless the techniques and reagents are
highly developed.
Compared to CD8+ responses to flu, there is an ap-
proximate ten-fold difference in frequency between individ-
ual CD4+ and CD8+ antigen reactive pools, similar to other
pathogens (Seder and Ahmed, 2003). This difference may be
due to the capacity of CD8+ T cells to proliferate more
extensively than CD4+ T cells (Foulds et al., 2002), thus
resulting in smaller clonal populations of CD4+ T cells
against any given viral epitope. However, viral epitope
density and clonal T cell survival also contribute to the
observable T cell pool, and therefore it cannot be assumed
that the magnitude of an antiviral CD4+ T cell response is
reduced simply because of reduced proliferative capacity. In
any case, it seems clear that intrinsic differences exist in the
programming of CD4+ and CD8+ T cell activation, prolifer-
ation, and acquisition of effector function.
Nevertheless, in spite of the low frequencies and
abundance of OVA323–339-specific cells, a subset of these
cells survived the contraction phase following viral clear-
ance, and recovered animals have an enhanced OVA323–339-
specific recall response characterized by rapid onset and
greater magnitude over primary challenge. These results
suggest that a viable memory population of OVA323–339-
specific CD4+ T cells is generated in response to WSN-
OVAII infection.
An advantage of our engineered system is that it is now
possible to use readily available TCR transgenics to
overcome some of the problems associated with low-
frequency T cells. This has given us the capability to study
virus-specific CD4+ cells at the single cell level, and has in
turn revealed some interesting aspects of CD4+ T cell
biology. Not surprisingly, it is clear that OVA323–339-
specific T cells proliferate and acquire differentiated effector
function when their activating antigen is present in the virus.
However, after infection with a virus lacking the activating
antigen, small numbers of primed OVA323–339-specific TCR
transgenic T cells are recruited to the lung tissue during the
acute inflammatory response. This does not occur if the cells
have been sorted for a naive (CD44low CD4+) phenotype.
Even when deliberately activated prior to transfer, though
they traffic to the lung, the majority of these non-specifically
recruited cells do not appear to proliferate significantly. This
suggests in vivo proliferation is not a prerequisite for
extravasation into tissue and that antigen regulates CD4+ T
cell proliferation, even during active inflammation. This
implies that T cells which are localized to inflamed tissue
and subsequently under the influence of inflammatory
mediators may not be responsive to these stimuli unless a
recent encounter with specific antigen has occurred. This
fits with the idea that CD4+ T cells acquire full differ-entiation as effectors in the draining lymph node subsequent
to encounter with specific antigen (Jenkins et al., 2001).
By tracking a population of surrogate virus-specific
CD4+ cells, we found evidence for the trafficking of primed
CD4+ T cells to the lung with specificities unrelated to the
viral infection. In particular, small numbers of in vitro
primed CD4 T cells localized to the lung regardless of
whether infection or antigen was present. This trafficking is
therefore largely independent from the presence of inflam-
mation in the lung, perhaps reflecting a steady state
recruitment of previously activated cells into this site. The
localization of memory CD4 T cells to non-lymphoid tissues
has been previously shown (Jenkins et al., 2001), but it is
not clear whether the presence of these cells reflects tissue
residence or constant replacement of tissue memory from
the blood. Our data suggest the latter, but do not rule out the
possibility that a small resident population exists. In
addition, since the tissue memory cells appear to undergo
minimal proliferation, it is likely that this population is
constantly replaced by the lymphoid tissues.
Recently, it has been suggested that memory CD8 T cells
appear in the infected lung in three distinct phases
(Woodland and Randall, 2004). There is a resident tissue
memory population at the outset, and a second population
that is recruited from the blood in an antigen-independent
manner. Neither of these first two populations has recently
proliferated. The third population is derived from the
lymphoid compartment, and has proliferated in response
to antigen. It is not yet known whether primed and memory
CD4 T cells behave in a similar fashion during virus
infections. However, our data suggest that, like the CD8
memory cells, primed CD4 T cells can either reside or be
recruited to the infected lung early in the infection without
regard to antigen-specificity or requiring recent cell
division. It is also clear that the later accumulation of
specific cells is an antigen-driven process for both CD4 and
CD8 T cells.
The significance of tissue-resident memory CD4 T cells
and early non-antigen-specific recruitment to the pulmonary
immune response is not clear. Prior vaccination for a CD4+
T cell response, or direct intratracheal transfer of virus-
specific CD4 T cells into the lung can produce an early
reduction in viral load (Hogan et al., 2001; Zhong et al.,
2000), but also appears to inhibit the subsequent CD8
response (Hogan et al., 2001; Zhong et al., 2000). In a
model of dermal contact sensitivity, early (but not late)
CD4+ T cell recruitment was dependent on selectin-
mediated interactions (Hwang et al., 2004). Late CD4+ T
cells accumulation was more dependent on a4-integrin
(Hwang et al., 2004). Blockade of P- and E-selectins within
the first 2 h of antigen exposure prevented early CD4 T cell
trafficking to the challenge site and abrogated the later
antigen-specific inflammatory response (Hwang et al.,
2004). Together, the data suggest that the small numbers
of CD4+ T cells that appear early in the immune response
can profoundly impact later events. It also suggests that
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regulated by distinct adhesion interactions.
In addition to their potential impact during the acute
response, these observations raise questions as to the role of
non-specifically recruited cells after the infection is
resolved. For instance, it is unknown whether they persist
following infection or whether these cells affect future
pulmonary infection or antigen encounters. With regard to
persisting cells in the lung tissue, even with cognate
activation and recruitment in the context of specific antigen,
within a month of infection, antigen-specific CD4 T cells
were below detection in the airways, and only small
numbers of cells were detectable in the lung tissue. It is
likely that the antigen-independent resident cells would be
at even lower frequencies and numbers, thus limiting the
impact of these local cells on subsequent encounters with
antigen. However, as suggested by the contact sensitivity
model mentioned above, resident cells and early non-
specific recruits from the blood may combine to shape later
events in the immune response. Future work will be aimed
at gaining insight into these important issues.
The WSN-OVAII viral system, together with currently
available transgenic mice and antibodies, constitute an
effective model to study antigen-specific CD4+ T cells on
a single-cell level during infection. It has several advantages
over previous approaches including the ability to track the
antigen-specific cells with antibodies, and the ability to
study the CD4+ T cell response to an identical antigen and
infection in two distinct strains of mice. The lung-specific
tropism of influenza also makes it a good model system with
which to study tissue-specific trafficking and function of
CD4+ effector and memory subsets (Sallusto et al., 1999).
Results reported in this paper confirm the importance of
specific antigen in activation and accumulation of effector T
cells in the lung during influenza infection. Further work
aimed at characterizing the nature of bystander T cells may
contribute to our understanding of the requirements for
CD4+ T cell activation, recruitment, effector function, and
survival during and after viral infection.Materials and methods
Cell culture
Madin Darby Canine Kidney (MDCK) cells were main-
tained in C-MEM supplemented with non-essential amino
acids and sodium pyruvate, and were grown at 37 -Cwith 5%
CO2. At 1 day prior to determination of viral titers via plaque
assay, MDCK cells were plated in 6-well plates at a density of
3  105 cells/ml in 2 ml maintenance medium.
Reverse genetics
Engineering of influenza/A/WSN was carried out as
previously described (Enami et al., 1990) using thepT3WSN-OVAII plasmid, with the NA gene flanked by
an upstream T3 RNA polymerase promoter and a down-
stream Ksp6321 site. Transcripts were complexed with
purified nucleoprotein and polymerase proteins. The resul-
tant complexes were then transfected into MDBK (bovine)
cells with helper virus. The progeny virus of the 1- infection
was recombinant, as tested by sequencing PCR-amplified
cDNA. Recombinant virus was subsequently purified,
titered on MDCK cells, and stored at 80 -C.
Mice
C57BL/6 (H-2b) and BALB/c (H-2d) mice were pur-
chased from Taconic laboratory (Germantown, NY).
Thy1.1+ B6.PL (H-2b) and H-2d (IAd-restricted) BALB/c
TCR Tg DO11.10 and H-2b (IAb-restricted) C57BL/6 OT-II
Thy 1.2+ mice were bred and maintained at the University of
Rochester Animal Housing facility (Rochester, N.Y.) in
specific pathogen-free conditions. OT-II  B6.PL Thy 1.1+
mice were bred and maintained at the Sidney Kimmel
Cancer Center (San Diego, C.A.) in specific pathogen-free
conditions.
T cell polarization and adoptive transfer
Spleen and lymph nodes of DO11.10 or OT-II TCR Tg
mice were removed and placed in HBSS. Tissues were
ground in homogenizers, and the resultant homogenate was
passed through nylon mesh into a 15 ml conical-bottom
tube. For unpolarized DO11.10 or OT-II cells: cells were
either left untreated or stained with CFSE. After treatment,
1–5  107 cells were injected i.v. into either BALB/c (for
DO11.10) or B6.PL (for OT-II) recipients. For OT-II Th1
cells: CD4+ T cells were magnetically separated using
negative selection with a CD4 enrichment cocktail from BD
(Imag) according to the manufacturer’s protocol. To gen-
erate TH1 cells, the cells were cultured for 4 days at 10
6/ml
with an equal number of C57BL/6 spleen cells that were
pretreated with 25 mg/ml mitomycin C. Media (RPMI
1640) containing 10% FBS, 2% PSG, 1 mM HEPES, and
5  105 M 2-ME was supplemented with 10 Ag/ml
OVA323–339 peptide, 10 Ag/ml anti-CD28 (37N51.1.1),
10 ng/ml rIL-2, 5 ng/ml rIL-12, and 10 Ag/ml anti-IL-4
(11B11). On day 4, the cells were harvested, washed, and 5
106 Tg+ cells were injected i.v. into C57BL/6 recipients.
Cell proliferation
CFSE: unpolarized DO11.10 cells were prepared as
above. Cells were resuspended at a concentration of 50 
106/ml, and CFSE was added at a final concentration of
5 AM for 5 min prior to adoptive transfer. BrdU: OT-II
TH1 cells were prepared as above, and then rested for 5
days by transfer of 7  106 into normal C57BL/6
recipients. The cells were reisolated from the spleens and
pooled peripheral LN by magnetic separation using
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Thy 1.2 conjugated beads (Imag). 3–5  106 Tg+ cells
were injected i.v. into a second set of recipients that
were uninfected or were infected i.n. with 1000 PFU of
either WSN-FLAG or WSN-OVAII. On the day of cell
transfer, all groups of mice were injected i.p. with 1 mg
BrdU and were treated with BrdU water (800 Ag/ml) for
6 days.
Viral infection
Stocks of WSN-OVAII or control WSN-HEL (Walker et
al., 1997), WSN-FLAG (Castrucci et al., 1992), or WSN-
OVAI (Topham et al., 2001) recombinant flu viruses in
allantoic fluid were thawed from 80 -C to room temper-
ature. Virus was diluted in 10 ml cold DPBS so that a 30-
Al volume would contain 500–1000 PFU of virus.
Recipient mice were first sedated with avertin (2,2,2-
tribromoethanol) i.p., then given a 30-Al intranasal inocu-
lation of virus.
Organ harvest
Mice were Avertin anesthetized and exsanguinated via
brachial artery. Bronchoalveolar lavage (BAL) samples were
collected by three intratracheal lung washes (with C-mem)
using a Teflon cannula attached to a 1-ml syringe. Lung
tissue, mediastinal lymph node (MLN), and spleen were
removed separately. BAL samples were subjected to 45 min
plastic adherence (for removal of alveolar macrophages)
prior to use. Lung tissue was ground in a tea strainer, filtered
through nylon mesh and run over Histopaque 1083 (Sigma)
for lymphocyte separation. MLN and spleen were homo-
genized and filtered through nylon mesh. All organ cells
were maintained in C-mem prior to use.
Plaque assay
Lungs were removed from infected mice, frozen at 80
-C, thawed and then homogenized in 1 ml HBSS. Virus was
then serial diluted 10-fold in HBSS/BSA. 0.5 ml of each
dilution of virus was added to individual wells of 6-well
plates containing a monolayer of fresh MDCK cells (see
Cell Culture). Plates were incubated 60 min for viral uptake.
Virus was then washed off with 2 ml HBSS/BSA. Equal
volumes of 1.2% SeaKem agarose (BioWhittaker, Wake-
rsville, MD) and 2 MEM supplemented with 100 Ag/ml
gentamycin (BioWhittaker, Wakersville, MD), 0.4% 1
phenol red and 0.5 Ag/ml TPCK trypsin (Worthington,
Lakewood, NJ) were mixed and added to cell monolayers at
2 ml/well. Plates were incubated 48 h at 37 -C with 5%
CO2. Plaques were visualized by staining agar overlay with
2 ml/well 1% crystal violet in 10% normal buffered formalin
for 2 h. After rinsing and drying plates, plaques were
enumerated and average PFU of triplicate wells was
reported.Flow cytometry
All Abs used for flow cytometric analysis were pur-
chased from BD PharMingen (San Diego, CA). Flow
cytometry was performed on a FACS Calibur (Becton
Dickinson) and analyzed with Cell Quest Pro (BD) analysis
software. Cell sorting was performed on a FACS Aria (BD)
and analyzed with FACS DiVa (BD) software.
ELISpot assay
IFN-g (R4-6A2) or IL-2 (JES6-1A12) capture Ab and
biotinylated a- IFN-g (XMG1.2) or a-IL-2 (JES6-5H4)
secondary Abs were purchased from BD Pharmingen.
C57BL/6 or BALB/c naive splenocytes, 500,000/well, were
peptide-pulsed (5Ag/ml for 2 h) with OVA323–339 (sequence
ISQAVHAAHAEINEAGR), NA161 – 175 (A/WSN/33
sequence SVAWSASACHDGVGW) or HA91–105 (A/WSN/
33 sequence LPARSWSYIVETPNS), infected with influ-
enza (10 PFU/cell), or left untreated and then used as APCs
in the 16–20 h overnight culture. Detection of secondary Ab
involved incubation with streptavidin-conjugated alkaline
phosphatase (Jackson Immunoresearch Labs, West Grove,
PA) and the Vector alkaline phosphatase substrate kit
(Burlingame, CA). ELISpot plates were analyzed using
the CTL Immunospot plate reader and counting software
(Cellular Technology).
LPS/OVA
LPS (Sigma serotype 0111:B4) and OVA323–339 peptide
were mixed at 1 mg/ml and 2 mg/ml, respectively, in DPBS.
LPS/OVAwas administered intranasally in 30 Al to Avertin-
anesthetized mice. Mice were monitored for recovery from
anesthesia.Acknowledgments
Portions of this work were supported by grants from the
American Lung Association (#RG-075-N) and the NIH
(NIH/NIA #RO1 AG021970-01) to D. Topham and NIH
R01 AI061615 and P01 AI46530 to L. Bradley. T. Chapman
is supported by NIH/NRSA training grant #2T32AI007169.References
Cardin, R.D., Brooks, J.W., Sarawar, S.R., Doherty, P.C., 1996. Progressive
loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the
absence of CD4+ T cells. J. Exp. Med. 184 (3), 863–871.
Castrucci, M.R., Kawaoka, Y., 1993. Biologic importance of neuraminidase
stalk length in influenza A virus. J. Virol. 67 (2), 759–764.
Castrucci, M.R., Bilsel, P., Kawaoka, Y., 1992. Attenuation of influenza A
virus by insertion of a foreign epitope into the neuraminidase. J. Virol.
66 (8), 4647–4653.
Castrucci, M.R., Hou, S., Doherty, P.C., Kawaoka, Y., 1994. Protection
T.J. Chapman et al. / Virology 340 (2005) 296–306306against lethal lymphocytic choriomeningitis virus (LCMV) infection
by immunization of mice with an influenza virus containing an
LCMV epitope recognized by cytotoxic T lymphocytes. J. Virol. 68
(6), 3486–3490.
Crowe, S.R., Miller, S.C., Brown, D.M., Adams, P.S., Dutton, R.W.,
Harmsen, A.G., Lund, F.E., Randall, T.D., Swain, S.L., and Woodland,
D.L. (in press). Uneven distribution of MHC class II epitopes within
influenza virus. Vaccine.
DeGrendele, H.C., Estess, P., Siegelman, M.H., 1997a. Requirement for
CD44 in activated T cell extravasation into an inflammatory site.
Science 278 (5338), 672–675.
DeGrendele, H.C., Kosfiszer, M., Estess, P., Siegelman, M.H., 1997b.
CD44 activation and associated primary adhesion is inducible via T cell
receptor stimulation. J. Immunol. 159 (6), 2549–2553.
Doherty, P.C., Topham, D.J., Tripp, R.A., Cardin, R.D., Brooks, J.W.,
Stevenson, P.G., 1997. Effector CD4+ and CD8+ T-cell mechanisms
in the control of respiratory virus infections. Immunol. Rev. 159,
105–117.
Eichelberger, M.C., Wang, M.L., Allan, W., Webster, R.G., Doherty, P.C.,
1991. Influenza virus RNA in the lung and lymphoid tissue of
immunologically intact and CD4-depleted mice. J. Gen. Virol. 72
(Pt 7), 1695–1698.
Enami, M., Luytjes, W., Krystal, M., Palese, P., 1990. Introduction of site-
specific mutations into the genome of influenza virus. Proc. Natl. Acad.
Sci. U.S.A. 87 (10), 3802–3805.
Ewing, C., Topham, D.J., Doherty, P.C., 1995. Prevalence and activation
phenotype of Sendai virus-specific CD4+ T cells. Virology 210 (1),
179–185.
Foulds, K.E., Zenewicz, L.A., Shedlock, D.J., Jiang, J., Troy, A.E.,
Shen, H., 2002. Cutting edge: CD4 and CD8 T cells are intrin-
sically different in their proliferative responses. J. Immunol. 168
(4), 1528–1532.
Garcia-Sastre, A., Muster, T., Barclay, W.S., Percy, N., Palese, P., 1994. Use
of a mammalian internal ribosomal entry site element for expression of
a foreign protein by a transfectant influenza virus. J. Virol. 68 (10),
6254–6261.
Harley, V.R., Ward, C.W., Hudson, P.J., 1989. Molecular cloning and
analysis of the N5 neuraminidase subtype from an avian influenza virus.
Virology 169 (1), 239–243.
Hogan, R.J., Zhong, W., Usherwood, E.J., Cookenham, T., Roberts, A.D.,
Woodland, D.L., 2001. Protection from respiratory virus infections can
be mediated by antigen- specific CD4 (+) T cells that persist in the
lungs. J. Exp. Med. 193 (8), 981–986.
Hwang, J.M., Yamanouchi, J., Santamaria, P., Kubes, P., 2004. A critical
temporal window for selectin-dependent CD4+ lymphocyte homing and
initiation of late-phase inflammation in contact sensitivity. J. Exp. Med.
199 (9), 1223–1234.
Jenkins, M.K., Khoruts, A., Ingulli, E., Mueller, D.L., McSorley, S.J.,
Reinhardt, R.L., Itano, A., Pape, K.A., 2001. In vivo activation of
antigen-specific CD4 T cells. Annu. Rev. Immunol. 19, 23–45.
Luytjes, W., Krystal, M., Enami, M., Pavin, J.D., Palese, P., 1989.
Amplification, expression, and packaging of foreign gene by influenza
virus. Cell 59 (6), 1107–1113.
Maassab, H.F., Bryant, M.L., 1999. The development of live attenuated
cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9
(4), 237–244.
Marelli-Berg, F.M., Frasca, L., Weng, L., Lombardi, G., Lechler, R.I., 1999.
Antigen recognition influences transendothelial migration of CD4+ T
cells. J. Immunol. 162 (2), 696–703.
Matloubian, M., Concepcion, R.J., Ahmed, R., 1994. CD4+ T cells are
required to sustain CD8+ cytotoxic T-cell responses during chronic viral
infection. J. Virol. 68 (12), 8056–8063.
Miyahira, Y., Garcia-Sastre, A., Rodriguez, D., Rodriguez, J.R., Murata, K.,
Tsuji, M., Palese, P., Esteban, M., Zavala, F., Nussenzweig, R.S., 1998.Recombinant viruses expressing a human malaria antigen can elicit
potentially protective immune CD8+ responses in mice. Proc. Natl.
Acad. Sci. U.S.A. 95 (7), 3954–3959.
Neumann, G., Kawaoka, Y., 2001. Reverse genetics of influenza virus.
Virology 287 (2), 243–250.
Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P.,
Hughes, M., Perez, D.R., Donis, R., Hoffmann, E., Hobom, G.,
Kawaoka, Y., 1999. Generation of influenza A viruses entirely from
cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 96 (16), 9345–9350.
Nimmerjahn, F., Kobelt, D., Steinkasserer, A., Menke, A., Hobom, G.,
Behrends, U., Bornkamm, G.W., Mautner, J., 2003. Efficient generation
and expansion of antigen-specific CD4+ T cells by recombinant
influenza viruses. Eur. J. Immunol. 33 (12), 3331–3341.
Pope, C., Kim, S.K., Marzo, A., Masopust, D., Williams, K., Jiang, J.,
Shen, H., Lefrancois, L., 2001. Organ-specific regulation of the CD8 T
cell response to Listeria monocytogenes infection. J. Immunol. 166 (5),
3402–3409.
Restifo, N.P., Bacik, I., Irvine, K.R., Yewdell, J.W., McCabe, B.J.,
Anderson, R.W., Eisenlohr, L.C., Rosenberg, S.A., Bennink, J.R.,
1995. Antigen processing in vivo and the elicitation of primary CTL
responses. J. Immunol. 154 (9), 4414–4422.
Riberdy, J.M., Christensen, J.P., Branum, K., Doherty, P.C., 2000.
Diminished primary and secondary influenza virus-specific CD8 (+)
T-cell responses in CD4-depleted Ig (/) mice. J. Virol. 74 (20),
9762–9765.
Robertson, J.M., Jensen, P.E., Evavold, B.D., 2000. DO11.10 and OT-II T
cells recognize a C-terminal ovalbumin 323–339 epitope. J. Immunol.
164 (9), 4706–4712.
Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A., 1999. Two
subsets of memory T lymphocytes with distinct homing potentials and
effector functions. Nature 401 (6754), 708–712.
Seder, R.A., Ahmed, R., 2003. Similarities and differences in CD4+ and
CD8+ effector and memory T cell generation. Nat. Immunol. 4 (9),
835–842.
Stephens, R., Chaplin, D.D., 2002. IgE cross-linking or lipopolysaccharide
treatment induces recruitment of Th2 cells to the lung in the absence of
specific antigen. J. Immunol. 169 (10), 5468–5476.
Stephens, R., Randolph, D.A., Huang, G., Holtzman, M.J., Chaplin, D.D.,
2002. Antigen-nonspecific recruitment of Th2 cells to the lung as a
mechanism for viral infection-induced allergic asthma. J. Immunol. 169
(10), 5458–5467.
Strobel, I., Krumbholz, M., Menke, A., Hoffmann, E., Dunbar, P.R.,
Bender, A., Hobom, G., Steinkasserer, A., Schuler, G., Grassmann, R.,
2000. Efficient expression of the tumor-associated antigen MAGE-3 in
human dendritic cells, using an avian influenza virus vector. Hum. Gene
Ther. 11 (16), 2207–2218.
Topham, D.J., Castrucci, M.R., Wingo, F.S., Belz, G.T., Doherty, P.C.,
2001. The role of antigen in the localization of naive, acutely activated,
and memory CD8 (+) T cells to the lung during influenza pneumonia.
J. Immunol. 167 (12), 6983–6990.
Walker, J.A., Sakaguchi, T., Matsuda, Y., Yoshida, T., Kawaoka, Y., 1992.
Location and character of the cellular enzyme that cleaves the
hemagglutinin of a virulent avian influenza virus. Virology 190 (1),
278–287.
Walker, W.S., Castrucci, M.R., Sangster, M.Y., Carson, R.T., Kawaoka, Y.,
1997. HEL-Flu: an influenza virus containing the hen egg lysozyme
epitope recognized by CD4+ T cells from mice transgenic for an
alphabeta TCR. J. Immunol. 159 (6), 2563–2566.
Woodland, D.L., Randall, T.D., 2004. Anatomical features of anti-viral
immunity in the respiratory tract. Semin. Immunol. 16 (3), 163–170.
Zhong, W., Marshall, D., Coleclough, C., Woodland, D.L., 2000. CD4+
T cell priming accelerates the clearance of Sendai virus in mice, but
has a negative effect on CD8+ T cell memory. J. Immunol. 164 (6),
3274–3282.
